1. Deciphering impact of single nucleotide polymorphisms on cotranscriptional modification in CCM gene mRNAs
   Concetta Scimone et al, 2022, American Journal of Physiology-Cell Physiology CrossRef
2. Epitranscriptome in Ischemic Cardiovascular Disease: Potential Target for Therapies
   Ana Quiles-Jiménez et al, 2022, Stroke CrossRef
3. Potential usages of A-to-I RNA editing patterns as diagnostic biomarkers
   David Rodriguez Morales et al, 2023, American Journal of Physiology-Cell Physiology CrossRef
4. Exercise Mitigates Endothelial Pyroptosis and Atherosclerosis by Downregulating NEAT1 Through N6-Methyladenosine Modifications
   Qingyuan Yang et al, 2023, ATVB CrossRef
5. Epigenetics of Early Cardiometabolic Disease: Mechanisms and Precision Medicine
   Andrea A. Baccarelli et al, 2023, Circulation Research CrossRef
6. RNA modification m6Am: the role in cardiac biology
   Daniel Benak et al, 2023, Epigenetics CrossRef
7. ALKBH5 inhibitors as a potential treatment strategy in heart failure—inferences from gene expression profiling
   Sumra Komal et al, 2023, Front. Cardiovasc. Med. CrossRef
8. Epitranscriptomic regulations in the heart
   D Benak et al, 2024, Physiol Res CrossRef
9. Drugging the Epitranscriptome
   Tanner W. Eggert et al, 2024 CrossRef
10. Epigenetic regulation of cardiovascular diseases induced by behavioral and environmental risk factors: Mechanistic, diagnostic, and therapeutic insights
    Feifei Bi et al, 2024, FASEB BioAdvances CrossRef